Ana Melero

Dr. Ana Melero

University of Valencia
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AGAntonio José Guillot
Antonio José Guillot
Ana Sara CordeiroAna Sara Cordeiro
Ana Sara Cordeiro
Ryan DonnellyRyan Donnelly
Ryan Donnelly
MMM. Carmen Montesinos
M. Carmen Montesinos
TGTeresa M Garrigues
Teresa M Garrigues
Ana MeleroAna Melero
Ana Melero
Microneedle arrays (MNA) are considered as one of the most promising resources to achieve systemic effects by transdermal delivery of drugs. They are designed as a minimally invasive, painless system which can bypass the stratum corneum, overcoming the potential drawbacks of subcutaneous injections and other transdermal delivery systems such as chemical enhancers, nano and microparticles, or physical treatments. As a trendy field in pharmaceutical and biomedical research, its applications are constantly evolving, even though they are based on very well-established techniques. The number of molecules administered by MNA are also increasing, with insulin and vaccines administration being the most investigated. Furthermore, MNA are being used to deliver cells and applied in other organs and tissues like the eyes and buccal mucosae. This review intends to offer a general overview of the current state of MNA research, focusing on the strategies, applications, and types of molecules delivered recently by these systems. In addition, some information about the materials and manufacturing processes is presented and safety data is discussed.

23 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MBMohammed Bhia
Mohammed Bhia
Mahzad MotallebiMahzad Motallebi
Mahzad Motallebi
Banafshe AbadiBanafshe Abadi
Banafshe Abadi
AZAtefeh Zarepour
Atefeh Zarepour
MPMiguel Pereira-Silva
Miguel Pereira-Silva
Mehdi ShakibaeiMehdi Shakibaei
Mehdi Shakibaei
Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nanoemulsions. These nanomedicine formulations of NRG have been applied as a potential treatment for several diseases, using a wide range of in vitro, ex vivo, and in vivo models and different routes of administration. From this review, it can be concluded that NRG is a potential therapeutic option for the treatment of various diseases such as cancer, neurological disorders, liver diseases, ocular disorders, inflammatory diseases, skin diseases, and diabetes when formulated in the appropriate nanocarriers.

17 February 2023 in Journal of Controlled Release
Verified
Journal Article
Open access
AGAntonio José Guillot
Antonio José Guillot
MMMiquel Martínez-Navarrete
Miquel Martínez-Navarrete
TGTeresa M. Garrigues
Teresa M. Garrigues
Ana MeleroAna Melero
Ana Melero
Lipid vesicles can provide a cost-effective enhancement of skin drug absorption when vesicle production process is optimised. It is an important challenge to design the ideal vesicle, since their properties and features are related, as changes in one affect the others. Here, we review the main components, preparation and characterization methods commonly used, and the key properties that lead to highly efficient vesicles for transdermal drug delivery purposes. We stand by size, deformability degree and drug loading, as the most important vesicle features that determine the further transdermal drug absorption. The interest in this technology is increasing, as demonstrated by the exponential growth of publications on the topic. Although long-term preservation and scalability issues have limited the commercialization of lipid vesicle products, freeze-drying and modern escalation methods overcome these difficulties, thus predicting a higher use of these technologies in the market and clinical practice.

1 August 2019 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
CSCaroline Magnani Spagnol
Caroline Magnani Spagnol
RARenata Assis
Renata Assis
IBIguatemy Lourenço Brunetti
Iguatemy Lourenço Brunetti
VIVera Isaac
Vera Isaac
HSHérida Regina Nunes Salgado
Hérida Regina Nunes Salgado
MCMarcos Corrêa
Marcos Corrêa

1 September 2011 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
AOAline Ferreira Ourique
Aline Ferreira Ourique
Ana MeleroAna Melero
Ana Melero
CSCristiane de Bona da Silva
Cristiane de Bona da Silva
USUlrich F. Schaefer
Ulrich F. Schaefer
APAdriana Pohlmann
Adriana Pohlmann
RBRuy Carlos Ruver Beck
Ruy Carlos Ruver Beck

17 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RORafaela Santos de Oliveira
Rafaela Santos de Oliveira
SFstephani fantaus
stephani fantaus
AGAntonio José Guillot
Antonio José Guillot
Ana MeleroAna Melero
Ana Melero
Ruy Carlos Ruver BeckRuy Carlos Ruver Beck
Ruy Carlos Ruver Beck
3D printing has been widely used for the personalization of therapies and on-demand production of complex pharmaceutical forms. Recently, 3D printing has been explored as a tool for the development of topical dosage forms and wound dressings. Thus, this review aims to present advances related to the use of 3D printing for the development of pharmaceutical and biomedical products for topical skin applications, covering plain dressing and products for the delivery of active ingredients to the skin. Based on the data acquired, the important growth in the number of publications over the last years confirms its interest. The semisolid extrusion technique has been the most reported one, probably because it allows the use of a broad range of polymers, creating the most diverse therapeutic approaches. 3D printing has been an excellent field for customizing dressings, according to individual needs. Studies discussed here imply the use of metals, nanoparticles, drugs, natural compounds and proteins and peptides for the treatment of wound healing, acne, pain relief, and anti-wrinkle, among others. The confluence of 3D printing and topical applications has undeniable advantages, and we would like to encourage the research groups to explore this field to improve the patient’s life quality, adherence and treatment efficacy.